Novartis AG (NVSEF)
127.40
+0.78
(+0.62%)
USD |
OTCM |
Dec 11, 16:00
Novartis EPS Diluted (Quarterly): 2.025 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Roche Holding AG | -- |
| BeOne Medicines Ltd. | 1.092 |
| AC Immune SA | -0.1964 |
| CRISPR Therapeutics AG | -1.166 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.93B |
| Revenue (Quarterly) | 13.91B |
| Total Expenses (Quarterly) | 9.981B |
| Enterprise Value | 267.15B |
| Gross Profit Margin (Quarterly) | 74.58% |
| Profit Margin (Quarterly) | 28.26% |
| Earnings Yield | 5.74% |
| Operating Earnings Yield | 6.87% |
| Normalized Earnings Yield | 6.043 |